Clinical trials sponsored by Hackensack Meridian Health
6
Recruiting trials
8
Conditions studied
Phase breakdown
Phase 1 1Phase 2 3Not applicable 3
Conditions studied
| Condition | Trials |
|---|---|
| Lung Cancer | 3 |
| Prostate Cancer | 2 |
| Anxiety | 1 |
| Heart Failure With Preserved Ejection Fraction | 1 |
| Heart failure | 1 |
| Osteogenic Sarcoma Recurrent | 1 |
| Prostate Adenocarcinoma | 1 |
| Urinary Retention | 1 |
Recruiting trials led by Hackensack Meridian Health
- Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
- Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
- Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- Support for Cancer Patients Awaiting News
- Transitions of Care Clinic (TOCC)
- Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
Common questions
How many trials is Hackensack Meridian Health recruiting for?
Hackensack Meridian Health is the lead sponsor of 6 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.